Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. - Wikidata - wikimedia - TriplyDB

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

http://www.wikidata.org/entity/Q33873085

about

The status of gene therapy for brain tumors Novel delivery strategies for glioblastoma Real-time monitoring of human blood-brain barrier disruption Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice Herpes simplex virus oncolytic therapy for pediatric malignancies Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.Gene therapy in the CNS.In situ use of suicide genes for therapy of brain tumours.Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler Disease Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications Oncolytic viruses as therapeutic agents.Gene therapy for high grade gliomas.Clinical development of experimental therapies for malignant glioma.Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells.Noninvasive gene targeting to the brain Gene therapy for the nervous system: challenges and new strategies.Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice.Immunotherapy of malignant brain tumors.Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain.Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes.Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.PNAs breach the blood-brain barrier?

P2860

Q24651009-C7D33705-46BD-4E76-8D5F-0ADF6353F78E Q27006099-C2F953BA-E94B-4E66-B595-29E07C9523DA Q30359368-9D49439E-F90A-4F8D-822A-66443742EFBD Q30434475-1659B851-6D79-420F-B377-09E905E893EE Q30957737-70702C9E-C9FB-43D1-98D8-FAA2380C1C18 Q33697504-46660E00-4638-4462-BB3D-68BD55A54EA9 Q33713824-9C12D28E-695E-4454-B76B-8017A59736AB Q33804845-34505CBA-64EA-4925-90FC-E51D0D2E5F3F Q33837123-B6422BEB-991D-47E7-8E4D-1F49AADFDB5E Q33841658-A3EFBC15-5389-43A0-A425-76DAEE2FD152 Q33974900-0D54F552-2D8D-4C4C-8CFB-25FF3386BDCB Q33985663-76541DD8-514E-478C-AB47-06E64C5985AC Q33995752-F83E9D58-86F1-40F8-8F15-7E4A6B10AA56 Q34329548-6C54410A-2273-4D90-B050-2161CC2EFDC6 Q34452062-F91CFB30-9FDD-4A25-A36C-8413626549C1 Q34782295-563FFE40-ACD1-421C-B89C-75E04D21C0DE Q35131235-1C8E1EFE-12F0-46EC-87E6-9357FC29B3E4 Q35163431-4DEC713F-41DF-4BBD-A5AE-136D4C050A96 Q35340196-17C4D461-F422-4E21-98C5-2603C93CBC6E Q35796504-0350CCAF-C53A-43FE-A51B-B227D3F269C1 Q35860573-8F2307E9-96D2-45DE-882B-E733CD8DEA9E Q36162929-6BA886CD-36A5-4BFB-959F-9E7838993B16 Q36200661-38E409B3-629C-4FAE-B67B-08DFC7BDCFCB Q36751597-F8F81DC3-9D95-42B7-9182-BBDDE68EC661 Q37346039-D81EB43E-8AEB-45AC-A2E0-9EB359F0630E Q40859254-91E8CF02-A463-4F3D-A618-5B5194F68165 Q41093799-F2DF80C8-41BC-4F08-8F23-DCD82766062E Q41333437-6B09E54D-AD8C-45E9-A398-14440BB5E865 Q41621942-CB8D5956-F049-413C-937D-D3ADDA2C73F4 Q44576921-63A7A475-E046-46EA-AE40-B2CD5BB6A061 Q45222017-C4578C46-4A18-4C68-B57C-CF9C157F5860 Q48147484-C42F84A6-9CC0-400D-82D9-E341A4BA2BB9

P2860

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

http://www.wikidata.org/entity/Q33873085

description

1995 nî lūn-bûn

@nan

1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@ast

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@en

type

label

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@ast

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@en

prefLabel

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@ast

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@en

P1433

Q33873085-18F85737-8679-4729-B6C9-DBF571C2D03A

P1476

Q33873085-C8E90237-7C48-45AB-8B72-2E2BF1F5100E

P2093

Q33873085-0CEBF410-6C08-45DF-B247-3761D0E60389

Q33873085-41829B53-9746-4517-A96D-D1204AC7352C

Q33873085-99F0222A-4ECD-4191-A0F2-EA02BF58D556

Q33873085-AA74F9D7-D0A4-4D2A-B136-EC5B03B0E4AF

Q33873085-B24DEBAB-1688-4C39-AF3E-FEE0DDC8E111

Q33873085-B5E5230F-44FA-409B-9FE2-DEB504F2F9C8

Q33873085-D63109EA-2903-4185-AE27-5A217F3C0A76

P2860

Q33873085-09969C02-501C-4545-BA0B-64E4B1CD5F61

Q33873085-1326A872-B32C-4192-B8B6-B26E0F7A57FE

Q33873085-1FE1A708-F6BB-4733-8554-EB5690F4C660

Q33873085-30E8CA1C-BE28-4618-9187-91E8B4FFDA7C

Q33873085-33D73476-F435-4793-AD75-D472CB2990EF

Q33873085-3506F92B-91B2-4948-BC0E-9694C95431C1

Q33873085-4099F741-F6EB-412E-975C-BF52487093D7

Q33873085-498D50C0-0282-4F34-9A65-4E719A70F907

Q33873085-4DAB65A6-E268-4281-AB0C-55DE3840E08F

Q33873085-687239A1-2CDF-43C2-9837-672730E8F15B

P304

Q33873085-A3F1395D-53C1-4684-81D2-2B18738B44BF

P31

Q33873085-E7255674-10DE-4BCA-BC9D-18D3BD183243

P356

Q33873085-95C05974-8FF2-4A42-8686-577F0B296F65

P407

Q33873085-B01EBDEF-E5E3-4FCD-9854-49BA8BC74EC7

P433

Q33873085-8788A54D-885A-42F8-AACF-C9760FB0E67B

P478

Q33873085-0E563485-B7F9-4E66-8EAA-9577844DFC77

P577

Q33873085-A8AD9EB1-F8C7-44AD-AA8B-CEFD018B11DD

P5875

Q33873085-776D68A9-EF65-46D1-95AD-B3A6E6AA0788

P698

Q33873085-387622E9-3E74-4036-97E3-D8FF9FC05A14

P921

Q33873085-37830E6A-E674-4C3F-A2AF-E8844494C2D2

Q33873085-5C5EB0A7-57CD-4ADF-978A-ACD0254058FD

P932

Q33873085-0FB8E42A-3B5B-4B91-9353-579A9336C7AF

P356

PNAS.92.21.9829

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Delivery of herpesvirus and ad ...... lood-brain barrier disruption.

@en

P2093

B L Davidson

http://www.w3.org/2001/XMLSchema#string

E A Neuwelt

http://www.w3.org/2001/XMLSchema#string

G Nilaver

http://www.w3.org/2001/XMLSchema#string

L L Muldoon

http://www.w3.org/2001/XMLSchema#string

M A Pagel

http://www.w3.org/2001/XMLSchema#string

R A Kroll

http://www.w3.org/2001/XMLSchema#string

X O Breakefield

http://www.w3.org/2001/XMLSchema#string

P2860

Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target.

Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy.

P304

9829-9833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.21.9829

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15631345

http://www.w3.org/2001/XMLSchema#string

P698

7568227

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

P932

40896

http://www.w3.org/2001/XMLSchema#string